Pulmonary artery capacitance and pulmonary vascular resistance as prognostic indicators in acute pulmonary embolism. Issue 2 (23rd February 2022)

• Record Type: Journal Article
• Authors: Quintero-Martinez, Juan A; Wysokinski, Waldemar E; Cordova-Madera, Sandra N; Mogollon, Renzo J; Garcia-Arango, Mariana; Vlazny, Danielle T; Houghton, Damon E; Casanegra, Ana I; Villarraga, Hector R
• Editors: Wahl, Denis
• Is Part Of: European Heart Journal Open. Volume 2:Issue 2(2022)
• Publication Date: 2022-02-23
• Subjects: Echocardiography -- Pulmonary embolism -- Right ventricle; 616
• DOI: 10.1093/ehjopen/oeac007
• Languages: English
• ISSNs: 2752-4191

Abstract

Abstract: Aims: The non-invasive calculation of right ventricular (RV) haemodynamics as pulmonary artery (PA) capacitance (PAC) and pulmonary vascular resistance (PVR) have proved to be feasible, easy to perform, and of high prognostic value. We, therefore, evaluated whether baseline PAC and PVR could predict clinical outcomes for patients with acute pulmonary embolism (PE). Methods and results: We prospectively followed 373 patients [mean (standard deviation) age, 64.1 (14.9) years; 58.4% were men, and 27.9% had cancer] who had acute PE and transthoracic echocardiography within 1 day of diagnosis from 1 March 2013 through 30 June 2020. Pulmonary artery capacitance was calculated as left ventricular stroke volume/(PA systolic pressure − PA diastolic pressure). Pulmonary vascular resistance was calculated as (tricuspid regurgitant velocity/RV outflow tract velocity time integral) × 10 + 0.16. These two variables were calculated retrospectively from the values obtained with transthoracic echocardiography. Pulmonary artery capacitance was acquired in 99 (27%) patients and PVR in 65 (17%) patients. Univariable and bivariable logistic regression analyses, and receiver operating characteristic curves were used to evaluate the ability of these haemodynamic measurements to predict mortality up to 6 months. After using bivariable models to adjust individually for age, cancer, and pulmonary hypertension. Pulmonary vascular resistance was associated with all-cause mortality at 3 months [area under the curve (AUC) 0.75, 95% confidence interval (CI) 0.61–0.86; P = 0.01], and 6 months (AUC 0.81; 95% CI 0.69–0.91; P ≤ 0.03). Pulmonary artery capacitance was associated with all-cause mortality at 30 days (AUC 0.95; 95% CI 0.82–0.99; P < 0.001) and 3 months (AUC 0.84; 95% CI 0.65–0.99; P = 0.003). Conclusion: Non-invasive measurement of RV haemodynamics could provide prognostic information of patients with acute PE. Pulmonary artery capacitance and PVR are potentially important predictors of all-cause mortality in these patients and should be explored in future studies. Graphical Abstract: